Search results for "Coronavirus"
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
https://immattersacp.org/weekly/archives/2021/12/21/1.htm
21 Dec 2021
N95 masks and gowns available from ACP
ACP members can participate in a bulk purchase of N95 masks and gowns, but orders must be received by 3 p.m. on Friday, June 26.
https://immattersacp.org/weekly/archives/2020/06/23/2.htm
23 Jun 2020
N95 masks and gowns available for purchase through ACP
ACP members can participate in a bulk purchase of N95 masks and gowns, but orders must be received by 3 p.m. ET on Monday, Aug. 24.
https://immattersacp.org/weekly/archives/2020/08/18/2.htm
18 Aug 2020
News on booster doses and omicron, COVID-19 and women's health, outpatient treatments
Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022
New research on booster doses, breakthrough infections, long-term COVID-19 symptoms
A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021
Research, regulators consider booster dose of COVID-19 vaccine
FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021
NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities
Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
https://immattersacp.org/weekly/archives/2021/06/22/1.htm
22 Jun 2021